Hot Warren Buffett Stocks To Invest In 2023


The stock market took a hit on Tuesday, although losses for major market averages were limited to less than 1%. The Dow Jones Industrial Average (DJINDICES:^DJI), S&P 500 (SNPINDEX:^GSPC), and Nasdaq Composite (NASDAQINDEX:^IXIC) all came under pressure, with worries about retail sales and the state of the consumer economy weighing on market sentiment.

Index

Percentage Change (Decline)

Point Change

Dow

(0.79%)

(282)

S&P 500

(0.71%)

(32)

Nasdaq Composite

(0.93%)

(138)

Data source: Yahoo! Finance.

Warren Buffett still gets a lot of attention, even in his 90s, and the leader of Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) has plenty of people watching his investment moves. Late Monday, the insurance giant released its latest holdings, and a couple of stocks saw big moves as a result. Below, we’ll look more closely at why Kroger (NYSE:KR) saw nice gains while General Motors (NYSE:GM) dropped.

Hot Warren Buffett Stocks To Invest In 2023: BancorpSouth, Inc.(BXS)


BancorpSouth, Inc., incorporated on February 17, 1982, is a financial holding company. The Company, through its principal bank subsidiary, BancorpSouth Bank (the Bank), conducts commercial banking and financial services operations in Alabama, Arkansas, Florida, Louisiana, Mississippi, Missouri, Tennessee, Texas and Illinois. The Company’s segments include Community Banking, Insurance Agencies, and General Corporate and Other. Its Community Banking segment provides a range of deposit products, commercial loans and consumer loans. Its Insurance Agencies segment serves as agents in the sale of commercial lines of insurance and full lines of property and casualty, life, health and employee benefits products and services. Its General Corporate and Other segment includes mortgage lending, trust services, credit card activities, investment services and other activities not allocated to the Community Banking or Insurance Agencies segments. The Bank and its subsidiaries provide a range of financial services to individuals and small-to-medium size businesses. The Bank operates an insurance agency subsidiary, which engages in sales of insurance products. The Bank’s wealth management department offers a range of services, including investment brokerage services, personal trust and estate services, certain employee benefit accounts and plans, including individual retirement accounts, and limited corporate trust functions.


Lending Activities

The Bank’s lending activities include both commercial loans and consumer loans. The Bank offers a range of commercial loan services, including term loans, lines of credit, equipment and receivable financing and agricultural loans. A range of short-to-medium term commercial loans, both secured and unsecured, are made available to businesses for working capital, including inventory and receivables, business expansion, including acquisition and development of real estate and improvements, and the purchase of equipment and machinery. The Bank also makes construction loans to real estate developers for the acquisition, development and construction of residential subdivisions. A portion of the Bank’s lending activities consists of the origination of fixed and adjustable rate residential mortgage loans secured by owner-occupied property located in its market areas. In addition, the Bank offers construction loans, second mortgage loans and home equity lines of credit. Non-residential consumer loans made by the Bank include loans for automobiles, recreation vehicles, boats, personal, such as secured and unsecured, and deposit account secured loans. The Company’s total loans and leases are approximately $10.4 billion.


Investment Activities

The Company uses the Bank’s securities portfolio to make various term investments, to provide a source of liquidity and to serve as collateral to secure certain types of deposits. The Company’s available for sale securities include the United States Government agencies, government agency issued residential mortgage-backed securities, government agency issued commercial mortgage-backed securities, taxable obligations of states and political subdivisions, tax-exempt obligations of states and political subdivisions, and other securities. The Company’s available-for-sale securities are approximately $2.1 billion.


Sources of Funds

Deposits are the Bank’s main source of funding its earning assets. Deposits include noninterest bearing demand deposits, interest bearing demand deposits, savings and other time deposits. The Bank’s total deposits are approximately $11.33 billion. The Company has approximately $62 million of short-term borrowings from the FHLB or the Federal Reserve. The Company has long-term borrowings from U.S. Bank National Association.

Advisors’ Opinion:

  • [By Shane Hupp]

    Bancorpsouth Bank (NYSE:BXS) – FIG Partners increased their FY2019 earnings estimates for shares of Bancorpsouth Bank in a report released on Wednesday, March 6th. FIG Partners analyst J. Rodis now anticipates that the bank will post earnings of $2.41 per share for the year, up from their previous estimate of $2.40. FIG Partners also issued estimates for Bancorpsouth Bank’s Q4 2019 earnings at $0.64 EPS and FY2020 earnings at $2.56 EPS.

  • [By Joseph Griffin]

    Rhumbline Advisers increased its stake in shares of Bancorpsouth Bank (NYSE:BXS) by 56.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 299,547 shares of the bank’s stock after buying an additional 107,999 shares during the period. Rhumbline Advisers owned 0.33% of Bancorpsouth Bank worth $7,830,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Bancorpsouth Bank (NYSE:BXS) – Equities researchers at Piper Jaffray Companies dropped their Q1 2019 earnings estimates for shares of Bancorpsouth Bank in a note issued to investors on Monday, January 28th. Piper Jaffray Companies analyst B. Rabatin now anticipates that the bank will post earnings per share of $0.56 for the quarter, down from their previous estimate of $0.57. Piper Jaffray Companies also issued estimates for Bancorpsouth Bank’s Q2 2020 earnings at $0.62 EPS, Q4 2020 earnings at $0.66 EPS and FY2020 earnings at $2.53 EPS.

  • [By Logan Wallace]

    Brean Capital reaffirmed their hold rating on shares of Bancorpsouth Bank (NYSE:BXS) in a research report released on Sunday.

    Other analysts also recently issued research reports about the stock. Zacks Investment Research upgraded shares of Bancorpsouth Bank from a hold rating to a buy rating and set a $38.00 price objective for the company in a report on Tuesday, June 19th. Stephens restated a buy rating and set a $37.00 price objective on shares of Bancorpsouth Bank in a report on Monday, August 27th. Eight investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average target price of $35.57.

Hot Warren Buffett Stocks To Invest In 2023: Amtech Systems Inc.(ASYS)


Amtech Systems, Inc., through its subsidiaries, engages in the design, assembly, sale, and installation of capital equipment and related consumables used in the manufacture of wafers, primarily for the solar and semiconductor industries. The company produces and sells horizontal diffusion furnaces used for various steps in the solar and semiconductor manufacturing processes, including diffusion, phosphorus tetrachloride doping, boron tribromide, low-pressure chemical vapor deposition, oxidation, and annealing; solar automation equipment, including mass wafer transfer systems, sorters, long-boat transfer systems, load station elevators, buffers, and conveyers; phosphorus silicate glass dry etch process equipment; plasma-enhanced chemical vapor deposition products, which applies an anti-reflective coating to solar wafers; semiconductor automation products; and small batch vertical furnaces. It also offers thermal processing systems, including related automation, parts, and s ervices to the solar/photovoltaic, semiconductor, silicon wafer, and microelectromechanical industries. In addition, the company manufactures and supplies polishing supplies that comprise wafer carriers, polishing templates, and double-sided polishing and lapping machines to the fabricators of light emitting diodes, optics, quartz, ceramics, and metal parts, as well as to manufacturers of medical equipment components and computer hard disks under the PR Hoffman brand name. Amtech Systems, Inc. markets its products primarily through sales personnel, as well as through a network of domestic and international independent sales representatives and distributors primarily in China, Taiwan, the United States, and Europe. The company was formerly known as Quartz Engineering & Materials, Inc. and changed its name to Amtech Systems, Inc. in 1987. Amtech Systems, Inc. was founded in 1981 and is based in Tempe, Arizona.


Advisors’ Opinion:

  • [By Stephan Byrd]

    SUMITOMO HEAVY/ADR (NASDAQ: ASYS) and Amtech Systems (NASDAQ:ASYS) are both industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.

  • [By Stephan Byrd]

    Brooks Automation (NASDAQ: BRKS) and Amtech Systems (NASDAQ:ASYS) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk.

Hot Warren Buffett Stocks To Invest In 2023: Diamondrock Hospitality Company(DRH)


DiamondRock Hospitality Company, incorporated on May 6, 2004, is a lodging-focused Maryland corporation operating as a real estate investment trust (REIT). The Company owns a portfolio of approximately 30 hotels and resorts throughout North America and the United States Virgin Islands that consists of over 10,925 guest rooms. Its primary business is to acquire, own, asset manage and renovate full-service hotel properties in the United States. Its portfolio is concentrated in gateway cities and destination resort locations. The Company conducts its business through an umbrella partnership REIT (UPREIT) in which the Company’s hotels are owned by subsidiaries of its operating partnership, DiamondRock Hospitality Limited Partnership. The Company is the sole general partner of its operating partnership and owns either directly or indirectly, all of the limited partnership units of its operating partnership. The Company leases all of its domestic hotels to taxable REIT subsidiary (TRS) lessees. In turn, the Company’s TRS lessees must engage a third-party management company to manage the hotels. Each of its hotels is managed by a third party and a number of its hotels are operated under a brand owned by lodging brand companies, such as Marriott International, Inc. (Marriott), Starwood Hotels & Resorts Worldwide, Inc. (Starwood) and Hilton Worldwide (Hilton).


The Company’s owned hotel properties include Chicago Marriott, Hilton Minneapolis, Westin Boston Waterfront Hotel, Lexington Hotel New York, Salt Lake City Marriott Downtown, Renaissance Worthington, Frenchman’s Reef & Morning Star Marriott Beach Resort, Orlando Airport Marriott, Westin San Diego, Westin Fort Lauderdale Beach Resort , Westin Washington, D.C. City Center, Hilton Boston Downtown, Vail Marriott Mountain Resort & Spa, Marriott Atlanta Alpharetta, Courtyard Manhattan/Midtown East, Hilton Garden Inn Times Square Central, Bethesda Marriott Suites, Hilton Burlington, JW Marriott Denver at Cherry Creek, Courtyard Manhattan/Fifth Avenue, The Lodge at Sonoma, a Renaissance Resort & Spa, Courtyard Denver Downtown, Hilton Garden Inn Chelsea/New York City, Renaissance Charleston, Inn at Key West and Hotel Rex.


The Company competes with Airbnb.

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of DRH opened at $10.74 on Tuesday. The stock has a market capitalization of $2.29 billion, a PE ratio of 10.91, a P/E/G ratio of 2.13 and a beta of 1.47. DiamondRock Hospitality has a fifty-two week low of $8.69 and a fifty-two week high of $12.99. The company has a debt-to-equity ratio of 0.49, a quick ratio of 2.48 and a current ratio of 2.48.

    WARNING: “BlackRock Inc. Sells 536,920 Shares of DiamondRock Hospitality (DRH)” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this report on another publication, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at www.tickerreport.com/banking-finance/4215056/blackrock-inc-sells-536920-shares-of-diamondrock-hospitality-drh.html.


    About DiamondRock Hospitality

  • [By Motley Fool Transcribers]

    Diamondrock Hospitality Co  (NYSE:DRH)Q4 2018 Earnings Conference CallFeb. 26, 2019, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    KKR Real Estate Finance Trust (NYSE:KREF) and DiamondRock Hospitality (NYSE:DRH) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, valuation, institutional ownership, risk and dividends.

Hot Warren Buffett Stocks To Invest In 2023: Protalix BioTherapeutics, Inc.(PLX)


Protalix BioTherapeutics, Inc., a biopharmaceutical company, together with its subsidiary, Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system in Israel and internationally. It offers taliglucerase alfa for injection, which is marketed under the ELELYSO brand name, as an enzyme replacement therapy for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease. The company’s product pipeline includes PRX-102, a therapeutic protein candidate for the treatment of Fabry disease; PRX-106, an oral antiTNF product candidate which is being developed as an orally-delivered anti-inflammatory treatment using plant cells as a natural capsule for the expressed protein; and PRX-112, an orally administered glucocerebrosidase enzyme (GCD) for the treatment of Gaucher patients utilizing oral delivery of the recombinant GCD produced and encapsulated within carrot cells. Its product pipeline also comprises PRX-110, a proprietary plant cell recombinant human Deoxyribonuclease 1 under development for the treatment of Cystic Fibrosis, to be administered by inhalation. Protalix BioTherapeutics, Inc. was founded in 1993 and is based in Carmiel, Israel.

Leave a Reply

Your email address will not be published.